natalizumab
biogen
['natalizumab']
dr tomas kalincik: compared ahsct - bone marrow stem cell treatment- with natalizumab to control disability in progressive ms, reduce relapses, and assess adverse events #ectrims2022 
Believe that research can improve our world. An advocate for equity, inclusion and social justice. Currently focused on accelerating research in #MS.